Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2023 was expected before 31 July 2024 and has not been filed.
-
Busy address KBO
87 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2022
Pharmaceutical industries Advice from Rixensart, company number BE0883798672, closed financial year 2022 with a result of € 3,960 after tax. For that financial year Pharmaceutical industries Advice recorded a gross margin of € 4,284 and equity of € 123,036. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 8, 2023.
€ 123,036
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,960
Profit after tax over the fiscal year.
€ 66,046
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2022. Retained profit grew to € 110,656.
People and assets in 2022
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 692
Book value of vehicles, furniture and equipment.
Debts at end 2022
None
No bank loans on the last day of the fiscal year.
€ 104,858
Supplier invoices still open on the last day of the fiscal year.
€ 182
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Pharmaceutical industries Advice?
What happened at Pharmaceutical industries Advice in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: profit of € 3,960. filed late Source: NBB ↗
- New establishment in Rixensart. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 182 in corporate taxes since 2022.
A new publication or filing at Pharmaceutical industries Advice? We notify you, reason included.
Follow Pharmaceutical industries AdviceDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharmaceutical industries Advice is Robert SAIVE.
Directors
According to the 2022 annual accounts
Robert SAIVE
Director
Establishments
Establishment units
Physical locations of this company
Avenue Franklin Roosevelt 104 box 29
1330 Rixensart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 87 companies are registered at this address.
All companies at this address →Etablissements Belge de Time Limit
€ -2,136 gross margin · 2025
LE BOIS DU GOUPIL
€ 90,032 gross margin · 2024
SUPNET
€ -1,496 gross margin · 2025
DELANDE & Cie
DIFFULEC
+82 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.798.672
- VAT number
- BE 0883.798.672
- Registered office
- Avenue Franklin Roosevelt 104 bus 29, 1330 Rixensart
- Names & denominations
- Pharmaceutical industries Advice
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 September 2006
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.